Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Gasco Industrial Corp.

US Class II Ongoing · initiated 2026-05-29

Subpotent drug

Gasco Industrial Corp.

US Class II Ongoing · initiated 2026-05-29

Subpotent drug

Gasco Industrial Corp.

US Class II Ongoing · initiated 2026-05-29

Subpotent drug

Gasco Industrial Corp.

US Class II Ongoing · initiated 2026-05-29

Subpotent drug

Gasco Industrial Corp.

US Class II Ongoing · initiated 2026-05-29

Subpotent drug

Hizentra

Canada Unclassified Ongoing · initiated 2026-05-29

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.

Guardian Drug Co. Inc.

US Class II Ongoing · initiated 2026-05-28

Presence of foreign substance: small metallic particles in chewable tablets.